Menu
← Oncology Approval Tracker
FDA DECISION ·
Thiotepa (Tepadina first generic)
thiotepa · MSN Laboratories
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic Tepadina for breast or ovarian adenocarcinoma, malignant intracavitary effusions, and superficial papillary bladder carcinoma.
LAMPGEN ANALYSIS
Why it matters
Added a generic source for several established uses of injectable thiotepa.
What research teams should watch
Tie preparation checks to the intended route and hazardous-drug precautions.
PRIMARY RECORDS